We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

The Clinical Utility of Prognostic Indices: The Proof of the Pudding Is in the Eating—Reply

George C. M. Siontis, MD; Ioanna Tzoulaki, PhD; John P. A. Ioannidis, MD, DSc
Arch Intern Med. 2012;172(2):194-195. doi:10.1001/archinte.172.2.195-a.
Text Size: A A A
Published online


In reply

Van Dijk et al raise several important points regarding prognostic models of chronic obstructive pulmonary disease, which would probably generalize to many other diseases. Prognostic tools should be evaluated in several sequential stages: initial model performance (model development), prospective validation in independent cohorts (external validation of a model), impact on patient management and outcome, and cost-effectiveness.1,2 However, even for established and widely used prognostic tools, many of these steps suffer from methodological limitations and, in many cases, are missing. Van Dijk et al are correct to highlight the paucity of evidence around their impact on patient management and clinical outcomes. Such important evidence would ideally come from randomized control trials, which compare the outcomes of patients whose treatment is guided by the proposed prognostic tool with the outcomes of patients who are treated without it. However, there are so many prognostic tools, that it is impossible to evaluate all of them in randomized control trials. Efforts should focus around those with most promising results.3 In selecting which models to test in randomized trials, one may wish to consider not only satisfactory, validated discriminating ability, but also what is the respective change in disease management that can be anticipated; how effective are the available preventive or treatment interventions for the disease and how much room exists for improvement; what is the expected cost to get the information required for building the model and to implement it in practice; and how likely it is that the model can be used widely by nonexpert health practitioners. Going through such a checklist is likely to eliminate most of the proposed prognostic models.



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





January 23, 2012
Wouter Diederik van Dijk, MD; Lisette van den Bemt, PhD; Chris van Weel, PhD
Arch Intern Med. 2012;172(2):194-195. doi:10.1001/archinte.172.2.194.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles